Gómez S - Search Results

1

Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.

Queiro R, Cañete JD, Montoro M, Gómez S, Cábez A; MAAPS study group. Queiro R, et al. Among authors: gomez s. Arthritis Res Ther. 2020 Apr 15;22(1):82. doi: 10.1186/s13075-020-02168-1. Arthritis Res Ther. 2020. PMID: 32295620 Free PMC article.

2

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

Queiro R, Cañete JD, Montilla C, Abad M, Montoro M, Gómez S, Cábez A; MAAPS study group. Queiro R, et al. Among authors: gomez s. Arthritis Res Ther. 2017 Mar 29;19(1):72. doi: 10.1186/s13075-017-1277-1. Arthritis Res Ther. 2017. PMID: 28356155 Free PMC article.

3

Drug immunogenicity in patients with inflammatory arthritis and secondary failure to tumour necrosis factor inhibitor therapies: the REASON study.

Balsa A, Sanmarti R, Rosas J, Martin V, Cabez A, Gómez S, Montoro M. Balsa A, et al. Among authors: gomez s. Rheumatology (Oxford). 2018 Apr 1;57(4):688-693. doi: 10.1093/rheumatology/kex474. Rheumatology (Oxford). 2018. PMID: 29365183

4

Expert recommendations on the psychological needs of patients with rheumatoid arthritis.

Leon L, Redondo M, Fernández-Nebro A, Gómez S, Loza E, Montoro M, Garcia-Vicuña R, Galindo M. Leon L, et al. Among authors: gomez s. Rheumatol Int. 2018 Dec;38(12):2167-2182. doi: 10.1007/s00296-018-4057-6. Epub 2018 May 28. Rheumatol Int. 2018. PMID: 29808295

5

Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.

Queiro R, Cañete JD, Montilla C, Abad MA, Montoro M, Gómez S, Cábez A; MAAPS Study Group. Queiro R, et al. Among authors: gomez s. J Rheumatol. 2019 Jul;46(7):710-715. doi: 10.3899/jrheum.180460. Epub 2019 Feb 1. J Rheumatol. 2019. PMID: 30709957 Free article.

6

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain.

Navarro F, Martinez-Sesmero JM, Balsa A, Peral C, Montoro M, Valderrama M, Gómez S, de Andrés-Nogales F, Casado MA, Oyagüez I. Navarro F, et al. Among authors: gomez s. Clin Rheumatol. 2020 Oct;39(10):2919-2930. doi: 10.1007/s10067-020-05087-3. Epub 2020 Apr 17. Clin Rheumatol. 2020. PMID: 32303858 Free PMC article.

7

Consensus document on the management preferences of patients with ulcerative colitis: points to consider and recommendations.

Casellas F, Guinard Vicens D, García-López S, González-Lama Y, Argüelles-Arias F, Barreiro-de Acosta M, Marín Sánchez L, Mendive JM, Saldaña R, Cabez A, Gómez S, Loza E. Casellas F, et al. Among authors: gomez s. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1514-1522. doi: 10.1097/MEG.0000000000001885. Eur J Gastroenterol Hepatol. 2020. PMID: 32804838 Review.

8

Gaps between research and recommendations in rheumatoid arthritis.

Ortiz AM, Silva Fernández L, Villaverde V, Abad MÁ, Maneiro JR, Candelas G, Gómez S, Valderrama M, Montoro M. Ortiz AM, et al. Among authors: gomez s. Rheumatol Int. 2021 Jan;41(1):57-66. doi: 10.1007/s00296-020-04724-z. Epub 2020 Oct 20. Rheumatol Int. 2021. PMID: 33079230 Review.

9

Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review.

Álvaro-Gracia JM, García-Llorente JF, Valderrama M, Gomez S, Montoro M. Álvaro-Gracia JM, et al. Among authors: gomez s. Rheumatol Ther. 2021 Mar;8(1):17-40. doi: 10.1007/s40744-020-00258-9. Epub 2020 Nov 27. Rheumatol Ther. 2021. PMID: 33245555 Free PMC article. Review.

10

Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain.

Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MÁ, Menchén L. Taxonera C, et al. Among authors: gomez s. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):73-83. doi: 10.1080/14737167.2021.1880324. Epub 2021 Feb 20. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33615953 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,737 results

Search Page

Filters